Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Telix Pharmaceuticals Limited
Acquired Company
ITM Isotope Technologies Munich SE
Melbourne
MunichBiotechnologyManufacturingHealth CareDescription
Telix Pharmaceuticals is set to merge with ITM in a deal valued at US$2.35 billion. This merger aims to combine the strengths of both companies in the radiopharmaceutical sector. The merger is expected to be a transformative step in addressing the growing demand for therapeutic isotopes. Approval from Telix holders is necessary as ITM is a private entity.
Fundz sees it the moment Telix Pharmaceuticals Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired ITM Isotope Technologies Munich SE?
ITM Isotope Technologies Munich SE was acquired by Telix Pharmaceuticals Limited, based in Melbourne. The deal was reported on October 15, 2026. Telix Pharmaceuticals Limited (ASX: TLX) is a leading pharmaceutical company specializing in advanced diagnostic and therapeutic radiopharmaceuticals. Telix Pharmaceuticals Limited is publicly traded (TLX) and operates in Biotechnology.
When did Telix Pharmaceuticals Limited acquire ITM Isotope Technologies Munich SE?
Telix Pharmaceuticals Limited's acquisition of ITM Isotope Technologies Munich SE was reported on October 15, 2026. Telix Pharmaceuticals is set to merge with ITM in a deal valued at US$2.35 billion. This merger aims to combine the strengths of both companies in the radiopharmaceutical sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ITM Isotope Technologies Munich SE do?
www.itm-radiopharma.com. It is privately held, operating in Manufacturing, and is based in Munich.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.